Reckitt CEO's $17B Predicament Post author:Sam Post published:December 26, 2017 Post category:BioPharma 2018 is the year for Rakesh Kapoor to show he’s worth it. Source: BioSpace You Might Also Like SoCal's Artelo Biosciences Inks $202M+ R&D Deal With the NEOMED Institute January 29, 2018 Pfizer, Arvinas Forge $830M Protein Degradation R&D Deal January 3, 2018 La Jolla Pharma Announces Financial Results For The Three And Six Months Ended June 30, 2017 And Recent Corporate Progress July 27, 2017
La Jolla Pharma Announces Financial Results For The Three And Six Months Ended June 30, 2017 And Recent Corporate Progress July 27, 2017
